Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection
Abstract Diabetic macular edema (DME), a complication of diabetes mellitus, is a leading cause of adult-onset blindness worldwide. Recently, intravitreal anti-VEGF injection has been used as a first-line treatment. This study analyzed the association between the genetic profile of patients with DME...
Main Authors: | Eun Hee Hong, Hoseok Yeom, Hyo Seon Yu, Jong Eun Park, Yong Un Shin, So-Young Bang, Heeyoon Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-26048-7 |
Similar Items
-
Efficacy of intravitreal injection of anti-VEGF combined with laser photocoagulation in treatment of diabetic macular edema
by: Xu Zhong
Published: (2018-01-01) -
The effects of intravitreal adalimumab injection on pseudophakic macular edema
by: Mohsen Farvardin, et al.
Published: (2020-07-01) -
Intravitreal gas injection for the treatment of diabetic macular edema
by: McHugh D, et al.
Published: (2011-10-01) -
Macular hole closure induced by intravitreal injection in diabetic macular edema
by: Sang Yoon Kim, et al.
Published: (2022-10-01) -
Correlation between responses to intravitreal injection of anti-VEGF and diabetic retinopathy extent in diabetic macular edema patients
by: Yue Huang, et al.
Published: (2017-02-01)